206 related articles for article (PubMed ID: 32160703)
21. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma.
Ali HEA; Abdel Hameed R; Effat H; Ahmed EK; Atef AA; Sharawi SK; Ali M; Abd Elmageed ZY; Abdel Wahab AH
Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):e51-e62. PubMed ID: 28750770
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma.
Karimkhanloo H; Mohammadi-Yeganeh S; Ahsani Z; Paryan M
Tumour Biol; 2017 Apr; 39(4):1010428317698361. PubMed ID: 28378640
[TBL] [Abstract][Full Text] [Related]
24. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
[TBL] [Abstract][Full Text] [Related]
25. Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).
Dhanasekaran R; Gabay-Ryan M; Baylot V; Lai I; Mosley A; Huang X; Zabludoff S; Li J; Kaimal V; Karmali P; Felsher DW
Oncotarget; 2018 Jan; 9(5):5517-5528. PubMed ID: 29464015
[TBL] [Abstract][Full Text] [Related]
26. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.
Chen CL; Tseng YW; Wu JC; Chen GY; Lin KC; Hwang SM; Hu YC
Biomaterials; 2015 Mar; 44():71-81. PubMed ID: 25617127
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression.
Fang W; Guo J; Cao Y; Wang S; Pang C; Li M; Dou L; Man Y; Huang X; Shen T; Li J
J Cell Mol Med; 2016 Aug; 20(8):1467-80. PubMed ID: 27019188
[TBL] [Abstract][Full Text] [Related]
28. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
Maurel M; Jalvy S; Ladeiro Y; Combe C; Vachet L; Sagliocco F; Bioulac-Sage P; Pitard V; Jacquemin-Sablon H; Zucman-Rossi J; Laloo B; Grosset CF
Hepatology; 2013 Jan; 57(1):195-204. PubMed ID: 22865282
[TBL] [Abstract][Full Text] [Related]
29. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
[TBL] [Abstract][Full Text] [Related]
30. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
Liu X
Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
34. Two-Step Forward Genetic Screen in Mice Identifies Ral GTPase-Activating Proteins as Suppressors of Hepatocellular Carcinoma.
Kodama T; Bard-Chapeau EA; Newberg JY; Kodama M; Rangel R; Yoshihara K; Ward JM; Jenkins NA; Copeland NG
Gastroenterology; 2016 Aug; 151(2):324-337.e12. PubMed ID: 27178121
[TBL] [Abstract][Full Text] [Related]
35. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
[TBL] [Abstract][Full Text] [Related]
36. miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma.
Xie F; Yuan Y; Xie L; Ran P; Xiang X; Huang Q; Qi G; Guo X; Xiao C; Zheng S
Onco Targets Ther; 2017; 10():885-894. PubMed ID: 28243124
[TBL] [Abstract][Full Text] [Related]
37. A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.
Si W; Shen J; Du C; Chen D; Gu X; Li C; Yao M; Pan J; Cheng J; Jiang D; Xu L; Bao C; Fu P; Fan W
Cell Death Differ; 2018 Feb; 25(2):406-420. PubMed ID: 29125598
[TBL] [Abstract][Full Text] [Related]
38. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.
Sui C; Xu F; Shen W; Geng L; Xie F; Dai B; Lu J; Zhang M; Yang J
Tumour Biol; 2015 Mar; 36(3):1511-8. PubMed ID: 25374061
[TBL] [Abstract][Full Text] [Related]
40. microRNA-622 acts as a tumor suppressor in hepatocellular carcinoma.
Song WH; Feng XJ; Gong SJ; Chen JM; Wang SM; Xing DJ; Zhu MH; Zhang SH; Xu AM
Cancer Biol Ther; 2015; 16(12):1754-63. PubMed ID: 26467022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]